MBX - MBX Biosciences Net earnings per share (EPS TTM)

MBX (MBX Biosciences, Inc.) - company brandmark

A lack of profitability and a dependence on investment define the financial profile of MBX Biosciences Inc (MBX). This 12-month EPS chart demonstrates a historical peak, with the -3.07 level representing the current value. MBX Biosciences Inc (MBX) attracts leading endocrinologists through stock options and research freedom. Currently, the R&D center is preparing Phase 2 data on peptide-based treatments for metabolic disorders.

MBX (MBX Biosciences Inc) Earnings per share for the last twelve months history from 09/14/2024 to 11/15/2026

MBX Bio - analytical breakdowns and key metrics (MBX)

- share price and expert price forecast:
Fundamental company analysis:MBX - MBX Biosciences, Inc.
Mass-produced product of MBX Biosciences, Inc.

For MBX Biosciences Inc (MBX), the specific annual income indicator reflects the net earnings per share over a rolling twelve-month period, allowing the company to filter out speculative noise from actual business growth. This metric assesses the efficiency of capitalizing scientific developments in endocrine peptides, demonstrating how strong R&D potential and regulatory compliance translate into actual returns for each shareholder.

Competitors of MBX Biosciences Inc

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share (EPS TTM) altimmune.com (ALT)|Net earnings per share (EPS TTM) AARD (aardvarktherapeutics.com)|Net earnings per share for the last four quarters Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biomea Fusion Corp BMEA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS